Industry Roundup: UK, US Claim Enforcement, Green Blender Expanding
This article was originally published in The Tan Sheet
Executive Summary
UK Hylo-Tear claim fails; Golden Caviar warned on anti-inflammatory claims, $1M for Green Blender expansion; Lycored updates logo, slogan; and more news in brief.
You may also be interested in...
Petition Challenges California Prop 65 Safe Harbor For Lead
In parallel with a lawsuit brought by the Mateel Environmental Justice Foundation, which seeks to eliminate the safe-harbor level for lead under Proposition 65, the Center for Environmental Health has filed a petition with California OEHHA asking for repeal or amendment of lead's maximum allowable dose level.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.